Molecular Diagnostics
Study Results Validate Use of Tumor Markers to Treat Metastatic Cancer
Promising results obtained in a recently conducted pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. More...17 Jun 2019
Custom NanoString Assay Detects Bowel Cancer Subtypes
Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide. The median overall survival of metastatic (m)CRC patients with unresectable disease remains around 24 months with standard chemotherapies. More...13 Jun 2019
Genetic Familial Hypercholesterolemia Prevalent in Premature CVD
Premature coronary artery disease (CAD) is a major cause of mortality and morbidity. Increased low-density lipoprotein-cholesterol (LDL-C) level is a major risk factor for CAD and thus the main target for its prevention. More...12 Jun 2019
Invasive Pulmonary Aspergillosis Diagnosed by Molecular Test
Invasive aspergillosis (IA) is a common opportunistic fungal infection, mainly affecting patients with severe and prolonged neutropenia. Early diagnosis of invasive pulmonary aspergillosis (IPA) is notoriously difficult, but crucial for prompt treatment initiation required to improve patient outcome. More...12 Jun 2019
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Slide Scanner System
NanoZoomer S540MD
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
In Other News
Sequencing Study Links DNA Alterations to Type 2 Diabetes
FDA Clears CT/NG Assays for Extragenital Testing
Genomic Analysis Uncovers Differences in Liver Cancer Subtypes
Oral Bacteria Found in Cerebral Emboli of Stroke Patients
CtDNA Forecasts Non-Metastatic Colorectal Cancer Recurrence
Stem Cell Transplantation Increases Risk of Infection-Related Mortality
Stem Cell Transplantation Increases Risk of Infection-Related Mortality
Liquid Biopsy Identifies Mutations Predicting Ovarian Cancer Treatment Response
Blood Test Measures Effectiveness of Aggressive Cancer Treatments
Rapid Assay Detects Pyrazinamide-Resistant Tuberculosis
Genomic Data Affects Prognosis of Advanced Prostate Cancer
Assay Stratifies Esophageal Cancer Patients for Treatment
Protein Panel Accurately Differentiates Forms of Ovarian Tumors
Clinical Trial Highlights Poor Prognosis for Bladder Cancer Patients
Prostate Cancer Severity Indicated by Location and Concentration of Syntaphilin
Clinical Validation Bolsters Liquid Biopsy Evidence Base
Serum HBV RNA Quantification Monitors Chronic Hepatitis B Infection
Breast Cancer Test Determines Most Effective Treatment
Urine Test Could Prevent Cervical Cancer
Biomarker Predicts Appropriate Immunotherapy for Cancer Patients
Oral HPV-DNA Persists after Oropharyngeal Cancer Treatment
Liquid Biopsy Utility Reinforced in Early Cancer Trials Results
Machine-Learning System Used to Diagnose Genetic Diseases
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.